相关实验视频

Updated: Jan 10, 2026

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

在使用胰岛素的糖尿病患者中评估微塑性暴露

Duygu Felek¹, Mustafa Fatih Erkoc², Merve Yaylacı³

¹Department of Internal Medicine, Faculty of Medicine, Yozgat Bozok University, Yozgat 66100, Türkiye.

|November 27, 2025

概括

微塑料可能有助于糖尿病的发展. 这项研究发现糖尿病患者的微塑料含量较高,与血糖控制不佳相关,这表明内分泌干扰作用.

科学领域:

环境科学环境科学
内分泌学在内分泌学.
毒理学毒理学毒理学

背景情况:

微塑料污染是一个日益严重的全球性问题.
目前正在调查微塑料对健康的潜在影响,包括内分泌干扰.
糖尿病是一种复杂的代谢障碍,患病率越来越高.

研究的目的:

调查血清中微塑料存在与糖尿病之间的关联.
评估糖尿病患者和健康对照人群之间的微塑料含量是否有差异.
探索微塑料含量和糖尿病患者的血糖控制标记物之间的关系.

主要方法:

在100名参与者 (50名糖尿病患者,50名对照人) 的血清微塑性量化中,使用LC/GC-MSMS和LCTOF MS.
糖尿病患者和健康对照者之间的微塑料含量比较.
血清微塑料水平,HbA1c和禁食葡萄糖之间的相关性分析.

主要成果:

与健康对照组 (1.50 ± 0.89 μg/mL) 相比,糖尿病患者的血清微塑性物质含量显著增加 (3.14 ± 1.30 μg/mL).
血清微塑性水平与HbA1c和禁食葡萄糖水平有很强的正相关性 (p = 0.001).
根据胰岛素注射频率,微塑料水平没有显著差异.

结论:

微塑料可能在糖尿病病变发生过程中发挥作用,可能作为内分泌干扰剂.
血清中微塑料的存在与糖尿病患者的血糖控制较差有关.
研究结果表明,微塑料有助于糖尿病的发展,而不是通过胰岛素治疗引入.

关键词:

在糖尿病中,糖尿病是血糖类的.在这种情况下,胰岛素胰岛素胰岛素.微塑料微塑料的使用

更多相关视频

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...